CRISIL assigns AA- rating on Dr Lal Pathlabs’ long-term bank facilities; Stock up 1%

The outlook is Stable. The credit rating agency also assigned a short-term rating of CRISIL A1+ on the company’s bank loan facilities.

Apr 22, 2021 11:04 IST India Infoline News Service

Dr Lal Pathlabs
CRISIL has assigned credit ratings on Dr Lal Pathlabs Limited’s total bank loan facilities of Rs60cr. The credit rating agency has assigned a long-term rating of CRISIL AA- with a Stable outlook. It also assigned a short-term rating of CRISIL A1+ on the company’s bank loan facilities.

“CRISIL has also confirmed that such letter (mentioning rating) will remain valid till March 31, 2022,” company said in a regulatory filing on Wednesday.

At around 11.17 am, Dr Lal Pathlabs Ltd was trading at Rs2931.45 up Rs28.25 or 0.97% from its previous closing of Rs2,903.20 per piece on the BSE.

Related Story

Open Free Demat Account (Rs699)